A comparison of three highly active antiretroviral treatment strategies consisting of non-nucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the presence of nucleoside reverse transcriptase inhibitors as initial therapy (CP (Q79438306)
Jump to navigation
Jump to search
scientific article published on 01 December 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A comparison of three highly active antiretroviral treatment strategies consisting of non-nucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the presence of nucleoside reverse transcriptase inhibitors as initial therapy (CP |
scientific article published on 01 December 2006 |
Statements
A comparison of three highly active antiretroviral treatment strategies consisting of non-nucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the presence of nucleoside reverse transcriptase inhibitors as initial therapy (CPCRA 058 FIRST Study): a long-term randomised trial (English)
Katherine Huppler Hullsiek
Rodger D MacArthur
Richard M Novak
Grace Peng
Li Chen
Ying Xiang
Mary van den Berg-Wolf
Christopher Henely
Barry Schmetter
Marjorie Dehlinger
CPCRA 058 Study Team
Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA)
1 December 2006